NR1I2 and Other metabolic disease: A similar theme plays out for PXR and CAR, and their crosstalks not only gained increased attention for the treatment of metabolic diseases, but they have also revealed context-specific effects of PXR and CAR activation in treating cancers [94,95,140,141,142].